A Bayesian design for phase II clinical trials with delayed responses based on multiple imputation.
A Bayesian design for phase II clinical trials with delayed responses based on multiple imputation.
复制标题
DOI：
10.1002/sim.6200
复制
发表时间：
2014-10-15
影响因子：
2
通讯作者：
Yuan, Ying
中科院分区：
文献类型：
--
作者：
Cai, Chunyan;Liu, Suyu;Yuan, Ying
Interimmonitoring is routinely conducted in phase II clinical trials to terminate the trial early if the experimental treatment is futile. Interim monitoring requires that patients’ responses be ascertained shortly after the initiation of treatment so that the outcomes are known by the time the interim decision must be made. However, in some cases, response outcomes require a long time to be assessed, which causes difficulties for interim monitoring. To address this issue, we propose a Bayesian trial design to allow for continuously monitoring phase II clinical trials in the presence of delayed responses. We treat the delayed responses as missing data and handle them using a multiple imputation approach. Extensive simulations show that the proposed design yields desirable operating characteristics under various settings and dramatically reduces the trial duration.
登录
查看更多内容
影响因子：
1.9
作者：
FLEMING, TR
通讯作者：
FLEMING, TR
影响因子：
2.2
作者：
Zohar, Sarah;Teramukai, Satoshi;Zhou, Yinghui
通讯作者：
Zhou, Yinghui
影响因子：
2
作者：
GREEN, SJ;DAHLBERG, S
通讯作者：
DAHLBERG, S
影响因子：
2
作者：
Zhao L;Taylor JM;Schuetze SM
通讯作者：
Schuetze SM
影响因子：
3.7
作者：
Yuan Y;Yin G
通讯作者：
Yin G